Wed, Jul 8, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Barclay Hedge Fund Index dips 0.09% in March +1.39% YTD

Thursday, April 17, 2014
Opalesque Industry Update - Hedge funds lost 0.09% in March, according to the Barclay Hedge Fund Index compiled by BarclayHedge. The Index is up 1.39% year to date.

“Global equity markets experienced their version of March Madness as fears of Russian expansionism, Fed tightening, and slowing growth in China spiked intra-month volatility,” says Sol Waksman, founder and president of BarclayHedge.

The Equity Short Bias Index fell 2.47% in March, the Technology Index lost 2.34%, Healthcare & Biotechnology gave up 1.29%, Global Macro was down 0.92%, and European Equities lost 0.90%.

“US growth stocks stumbled at month-end as share prices of hedge fund favorites such as Google, Facebook, and Yahoo dropped sharply,” says Waksman.

On the positive side, the Distressed Securities Index was up 0.86% in March, Convertible Arbitrage gained 0.79%, and Fixed Income Arbitrage gained 0.50%.

“In spite of higher interest rates and lower prices on US Treasuries, prices on high yield bonds rose and contributed to the narrowing of credit spreads, which typically provides a favorable backdrop for relative value fixed income trades,” says Waksman.

At the end of the first quarter, the Healthcare & Biotechnology Index is the strongest performer with a 9.63% gain. Distressed Securities are up 4.20%, the Event Driven Index has gained 3.03%, and European Equities have returned 2.82%.

After three months, Equity Short Bias is down 4.78%, Pacific Rim Equities have lost 2.06%, Global Macro has given up 1.70%, and Emerging Markets are down 1.61%.

The Barclay Fund of Funds Index lost 0.73% in March, but remains up 0.62% year to date.

BarclayHedge

Press Release

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Opalesque Exclusive: New systematic strategy managed alongside research firm outperforms S&P500[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: An emerging CTA manager explains how he runs his strategy, which is based on an index produced by a research firm. Peter Turk is head of

  2. Opalesque Exclusive: New systematic strategy embraces machine learning[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: The founder of a New York-based systematic trading firm, which offers a hybrid between alpha strategies and alternative feta at lower fees, describes his approa

  3. Larry Robbins' hedge fund Glenview buys 1m Tenet Healthcare shares[more]

    Komfie Manalo, Opalesque Asia: Glenview Capital Management said it bought an additional 979,482 shares at Tenet Healthcare Corp valued at $53.80 million, raising its stakes in the healthcare services company to 15.16%, reported

  4. Legal - Grayson’s hedge funds under scrutiny for possible ethics violations, Court rejects hedge fund’s motion to block merger of Samsung affiliates[more]

    Grayson’s hedge funds under scrutiny for possible ethics violations From Freebeacon.com: Rep. Alan Grayson is finding himself in hot water over managing hedge funds that bear his name, actions that are in possible violation of House ethics rules. Sitting members of Congress are prohibite

  5. Hedge funds decline in June as stocks tumble on Greek woes[more]

    From Bloomberg.com: Hedge funds posted losses across strategies last month as uncertainty over whether Greece will remain in the euro sent global stock markets tumbling. Winton Capital Management declined about 3.1 percent in June in its $12.1 billion Winton Futures Fund, leaving it down 1.9 percent

 

banner